Tandem Diabetes Care Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
2025.08.06 21:52
portai
I'm PortAI, I can summarize articles.

Tandem Diabetes Care Inc reported a quarterly adjusted loss of 48 cents per share for the quarter ended June 30, matching last year's results. Revenue increased by 8.5% to $240.68 million, surpassing analyst expectations. The company reported a total loss of $52.4 million and its shares fell by 18.7% this quarter. Analysts maintain a "hold" rating, with a median 12-month price target of $27.00, indicating a potential upside of 46.7% from the last closing price of $14.39.

  • Tandem Diabetes Care Inc (TNDM.OQ) reported a quarterly adjusted loss of 48 cents​​ per share for the quarter ended June 30, identical to the same quarter last year. The mean expectation of twenty three analysts for the quarter was for a loss of 40 cents per share. Wall Street expected results to range from -57 cents to -32 cents per share.
  • Revenue rose 8.5% to $240.68 million from a year ago; analysts expected $238.57 million.
  • Tandem Diabetes Care Inc’s reported EPS for the quarter was a loss of 78 cents​.
  • The company reported a quarterly loss of $52.4 million.
  • Tandem Diabetes Care Inc shares had fallen by 18.7% this quarter and lost 57.9% so far this year. FORECAST CHANGES
  • The mean earnings estimate of analysts had risen by about 1.2% in the last three months.​
  • In the last 30 days, there have been no negative revisions of earnings estimates RECOMMENDATIONS
  • The current average analyst rating on the shares is “hold” and the breakdown of recommendations is 11 “strong buy” or “buy,” 11 “hold” and 2 “sell” or “strong sell.” The average consensus recommendation for the medical equipment, supplies & distribution peer group is “buy.”
  • Wall Street’s median 12-month price target for Tandem Diabetes Care Inc is $27.00, about 46.7% above its last closing price of $14.39 This summary was machine generated from LSEG data August 6 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Jun. 30 2025 -0.40 -0.48 Missed

Mar. 31 2025 -0.61 -0.66 Missed

Dec. 31 2024 -0.23 0.01 Beat

Sep. 30 2024 -0.41 -0.35 Beat

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.